GoodRx Holdings, Inc.·4

Mar 14, 5:12 PM ET

Voermann Karsten 4

4 · GoodRx Holdings, Inc. · Filed Mar 14, 2024

Insider Transaction Report

Form 4
Period: 2024-03-12
Voermann Karsten
Chief Financial Officer
Transactions
  • Award

    Restricted Stock Unit

    2024-03-12+357,168357,168 total
    Class A Common Stock (357,168 underlying)
  • Award

    Stock Option (Right to Buy)

    2024-03-12+515,793515,793 total
    Exercise: $7.22Exp: 2034-03-12Class A Common Stock (515,793 underlying)
Holdings
  • Class A Common Stock

    211,952
Footnotes (3)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
  • [F2]The restricted stock unit award will vest as to 25% of the underlying shares on January 8, 2025 with the remaining 75% of the underlying shares to vest in approximately equal quarterly installments thereafter for 12 quarters.
  • [F3]The option will vest and become exercisable as to 25% of the underlying shares on January 8, 2025 with the remaining 75% underlying shares to vest in approximately equal quarterly installments thereafter for 12 quarters.

Documents

1 file
  • 4
    wk-form4_1710450723.xmlPrimary

    FORM 4